Hims & Hers Health (HIMS) Long-Term Investments (2019 - 2025)

Hims & Hers Health's (HIMS) quarterly Long-Term Investments came in at $351.3 million in Q4 2025, down 19.87% quarter-over-quarter from $438.3 million in Q3 2025.

Hims & Hers Health (HIMS) Long-Term Investments (2019 - 2025) Analysis & Trends

Hims & Hers Health has disclosed Long-Term Investments across 3 years of filings, most recently posting $351.3 million for Q4 2025.

  • Long-Term Investments for Q4 2025 came in at $351.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $351.3 million (changed N/A YoY), and the FY2025 annual result was $351.3 million, changed N/A from the prior year.
  • Long-Term Investments came in at $351.3 million for Q4 2025 at Hims & Hers Health, down from $438.3 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $438.3 million in Q3 2025 to a low of $351.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 1.32 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.33 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 26.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.90 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 351.26 Mn
Sep 30, 2025 438.34 Mn
Dec 31, 2020 204.53 Mn
Sep 30, 2020 204.48 Mn
Jun 30, 2020 204.73 Mn
Mar 31, 2020 204.69 Mn
Dec 31, 2019 203.11 Mn
Sep 30, 2019 202.14 Mn